Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D

Molecular and Cellular Biology

Volumn 30, Issue 22, 2010, Pages 5406-5420

  Kim, Hyun Wook ^a   Ha, Sang Hoon ^a,d   Lee, Mi Nam ^a   Huston, Elaine ^b   Kim, Do Hyung ^c   Jang, Sung Key ^a   Suh, Pann Ghill ^a   Houslay, Miles D ^b   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; RHEB PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROLYSIS; INHIBITION KINETICS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ANIMALS; CELL LINE; CELLS, CULTURED; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; FIBROBLASTS; HUMANS; MICE; MONOMERIC GTP-BINDING PROTEINS; NEUROPEPTIDES; PROTEIN BINDING; SECOND MESSENGER SYSTEMS; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 78649567118     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00217-10     Document Type: Article

References (96)

1. Alvarez, R., C. Sette, D. Yang, R. M. Eglen, R. Wilhelm, E. R. Shelton, and M. Conti. 1995. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol. Pharmacol. 48:616-622.
2. Aspuria, P. J., and F. Tamanoi. 2004. The Rheb family of GTP-binding proteins. Cell. Signal. 16:1105-1112.
3. Bai, X., D. Ma, A. Liu, X. Shen, Q. J. Wang, Y. Liu, and Y. Jiang. 2007. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318:977-980.
4. Baillie, G. S., E. Huston, G. Scotland, M. Hodgkin, I. Gall, A. H. Peden, C. MacKenzie, E. S. Houslay, R. Currie, T. R. Pettitt, A. R. Walmsley, M. J. Wakelam, J. Warwicker, and M. D. Houslay. 2002. TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-pecific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid. J. Biol. Chem. 277:28298-28309.
5. Baillie, G. S., A. Sood, I. McPhee, I. Gall, S. J. Perry, R. J. Lefkowitz, and M. D. Houslay. 2003. Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc. Natl. Acad. Sci. U. S. A. 100:940-945.
6. Beard, M. B., A. E. Olsen, R. E. Jones, S. Erdogan, M. D. Houslay, and G. B. Bolger. 2000. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J. Biol. Chem. 275:10349-10358.
7. Bolger, G. B., G. S. Baillie, X. Li, M. J. Lynch, P. Herzyk, A. Mohamed, L. H. Mitchell, A. McCahill, C. Hundsrucker, E. Klussmann, D. R. Adams, and M. D. Houslay. 2006. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem. J. 398:23-36.
8. Bolger, G. B., S. Erdogan, R. E. Jones, K. Loughney, G. Scotland, R. Hoffmann, I. Wilkinson, C. Farrell, and M. D. Houslay. 1997. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem. J. 328(Pt. 2):539-548.
9. Bos, J. L. 2006. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31:680-686.
10. Brugarolas, J., K. Lei, R. L. Hurley, B. D. Manning, J. H. Reiling, E. Hafen, L. A. Witters, L. W. Ellisen, and W. G. Kaelin, Jr. 2004. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893-2904.
11. Brunn, G. J., C. C. Hudson, A. Sekulic, J. M. Williams, H. Hosoi, P. J. Houghton, J. C. Lawrence, Jr., and R. T. Abraham. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99-101.
12. Burnett, P. E., R. K. Barrow, N. A. Cohen, S. H. Snyder, and D. M. Sabatini. 1998. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U. S. A. 95:1432-1437.
13. Chappell, S. A., J. P. LeQuesne, F. E. Paulin, M. L. deSchoolmeester, M. Stoneley, R. L. Soutar, S. H. Ralston, M. H. Helfrich, and A. E. Willis. 2000. A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene 19:4437-4440.
14. Chen, X., L. Xu, P. Radcliffe, B. Sun, and A. W. Tank. 2008. Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons. Mol. Pharmacol. 73:1816-1828.
15. Collins, D. M., H. Murdoch, A. J. Dunlop, E. Charych, G. S. Baillie, Q. Wang, F. W. Herberg, N. Brandon, A. Prinz, and M. D. Houslay. 2008. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through protein kinase A (PKA). Cell. Signal. 20:2356-2369.
16. Conti, M., and J. Beavo. 2007. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76:481-511.
17. Conti, M., W. Richter, C. Mehats, G. Livera, J. Y. Park, and C. Jin. 2003. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278:5493-5496.
18. Creighton, J., B. Zhu, M. Alexeyev, and T. Stevens. 2008. Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation. J. Cell Sci. 121:110-119.
19. Di Benedetto, G., A. Zoccarato, V. Lissandron, A. Terrin, X. Li, M. D. Houslay, G. S. Baillie, and M. Zaccolo. 2008. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ. Res. 103:836-844.
20. Dodge, K. L., S. Khouangsathiene, M. S. Kapiloff, R. Mouton, E. V. Hill, M. D. Houslay, L. K. Langeberg, and J. D. Scott. 2001. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 20:1921-1930.
21. Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942-1945.
22. Fuller, S. J., C. J. Gaitanaki, and P. H. Sugden. 1990. Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Stimulation of translation is mediated through the alpha 1-adrenoceptor. Biochem. J. 266:727-736.
23. Garami, A., F. J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S. C. Kozma, E. Hafen, J. L. Bos, and G. Thomas. 2003. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11:1457-1466.
24. Gingras, A. C., B. Raught, and N. Sonenberg. 2004. mTOR signaling to translation. Curr. Top. Microbiol. Immunol. 279:169-197.
25. Gingras, A. C., B. Raught, and N. Sonenberg. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807-826.
26. Ha, S. H., D. H. Kim, I. S. Kim, J. H. Kim, M. N. Lee, H. J. Lee, S. K. Jang, P. G. Suh, and S. H. Ryu. 2006. PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell. Signal. 18:2283-2291.
27. Han, P., P. Sonati, C. Rubin, and T. Michaeli. 2006. PDE7A1, a cAMP-specific phosphodiesterase, inhibits cAMP-dependent protein kinase by a direct interaction with C. J. Biol. Chem. 281:15050-15057.
28. Hoffmann, R., I. R. Wilkinson, J. F. McCallum, P. Engels, and M. D. Houslay. 1998. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem. J. 333(Pt. 1):139-149.
29. Holcik, M., and N. Sonenberg. 2005. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6:318-327.
30. Holz, M. K., and J. Blenis. 2005. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J. Biol. Chem. 280:26089-26093.
31. Houslay, M. D. 2009. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35:91-100.
32. Houslay, M. D., and D. R. Adams. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370:1-18.
33. Houslay, M. D., G. S. Baillie, and D. H. Maurice. 2007. cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular tool-box for generating compartmentalized cAMP signaling. Circ. Res. 100:950-966.
34. Houslay, M. D., P. Schafer, and K. Y. Zhang. 2005. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov. Today 10:1503-1519.
35. Hsu, Y. C., J. J. Chern, Y. Cai, M. Liu, and K. W. Choi. 2007. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445:785-788.
36. Hutchinson, D. S., E. Chernogubova, O. S. Dallner, B. Cannon, and T. Bengtsson. 2005. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48:2386-2395.
37. Inoki, K., and K. L. Guan. 2006. Complexity of the TOR signaling network. Trends Cell Biol. 16:206-212.
38. Inoki, K., T. Zhu, and K. L. Guan. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590.
39. Jacinto, E., and M. N. Hall. 2003. Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell Biol. 4:117-126.
40. Kim, D. H., D. D. Sarbassov, S. M. Ali, J. E. King, R. R. Latek, H. Erdjument-Bromage, P. Tempst, and D. M. Sabatini. 2002. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163-175.
41. Kim, J. H., K. Y. Paek, K. Choi, T. D. Kim, B. Hahm, K. T. Kim, and S. K. Jang. 2003. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 23:708-720.
42. Kwon, G., C. A. Marshall, K. L. Pappan, M. S. Remedi, and M. L. McDaniel. 2004. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 53(Suppl. 3):S225-S232.
43. Lecureuil, C., S. Tesseraud, E. Kara, N. Martinat, A. Sow, I. Fontaine, C. Gauthier, E. Reiter, F. Guillou, and P. Crepieux. 2005. Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells. Mol. Endocrinol. 19:1812-1820.
44. Lee, M. N., S. H. Ha, J. Kim, A. Koh, C. S. Lee, J. H. Kim, H. Jeon, D. H. Kim, P. G. Suh, and S. H. Ryu. 2009. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol. Cell. Biol. 29:3991-4001.
45. Li, Y., Y. Wang, E. Kim, P. Beemiller, C. Y. Wang, J. Swanson, M. You, and K. L. Guan. 2007. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J. Biol. Chem. 282:35803-35813.
46. Lim, J., G. Pahlke, and M. Conti. 1999. Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain. J. Biol. Chem. 274:19677-19685.
47. Ling, J., S. J. Morley, and J. A. Traugh. 2005. Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2. EMBO J. 24:4094-4105.
48. Long, X., Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch. 2005. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15:702-713.
49. Lugnier, C. 2006. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109:366-398.
50. Lynch, M. J., G. S. Baillie, A. Mohamed, X. Li, C. Maisonneuve, E. Klussmann, G. van Heeke, and M. D. Houslay. 2005. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells. J. Biol. Chem. 280:33178-33189.
51. Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P. P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179-193.
52. Ma, X. M., and J. Blenis. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10:307-318.
53. Ma, X. M., S. O. Yoon, C. J. Richardson, K. Julich, and J. Blenis. 2008. SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133:303-313.
54. MacKenzie, S. J., G. S. Baillie, I. McPhee, C. MacKenzie, R. Seamons, T. McSorley, J. Millen, M. B. Beard, G. van Heeke, and M. D. Houslay. 2002. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in upstream conserved region 1 (UCR1). Br. J. Pharmacol. 136:421-433.
55. McCahill, A., T. McSorley, E. Huston, E. V. Hill, M. J. Lynch, I. Gall, G. Keryer, B. Lygren, K. Tasken, G. van Heeke, and M. D. Houslay. 2005. In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region. Cell. Signal. 17:1158-1173.
56. McSorley, T., E. Stefan, V. Henn, B. Wiesner, G. S. Baillie, M. D. Houslay, W. Rosenthal, and E. Klussmann. 2006. Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells. Eur. J. Cell Biol. 85:673-678.
57. Mongillo, M., T. McSorley, S. Evellin, A. Sood, V. Lissandron, A. Terrin, E. Huston, A. Hannawacker, M. J. Lohse, T. Pozzan, M. D. Houslay, and M. Zaccolo. 2004. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ. Res. 95:67-75.
58. Murdoch, H., S. Mackie, D. M. Collins, E. V. Hill, G. B. Bolger, E. Klussmann, D. J. Porteous, J. K. Millar, and M. D. Houslay. 2007. Isoformselective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 27:9513-9524.
59. Oki, N., S. I. Takahashi, H. Hidaka, and M. Conti. 2000. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation. J. Biol. Chem. 275:10831-10837.
60. Perry, S. J., G. S. Baillie, T. A. Kohout, I. McPhee, M. M. Magiera, K. L. Ang, W. E. Miller, A. J. McLean, M. Conti, M. D. Houslay, and R. J. Lefkowitz. 2002. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298:834-836.
61. Rall, T. W., and E. W. Sutherland. 1958. Formation of a cyclic adenine ribonucleotide by tissue particles. J. Biol. Chem. 232:1065-1076.
62. Rehmann, H., A. Wittinghofer, and J. L. Bos. 2007. Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat. Rev. Mol. Cell Biol. 8:63-73.
63. Rich, T. C., W. Xin, C. Mehats, K. A. Hassell, L. A. Piggott, X. Le, J. W. Karpen, and M. Conti. 2007. Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells. Am. J. Physiol. Cell Physiol. 292:C319-C331.
64. Rosenberg, D., L. Groussin, E. Jullian, K. Perlemoine, X. Bertagna, and J. Bertherat. 2002. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann. N. Y. Acad. Sci. 968:65-74.
65. Sancak, Y., T. R. Peterson, Y. D. Shaul, R. A. Lindquist, C. C. Thoreen, L. Bar-Peled, and D. M. Sabatini. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496-1501.
66. Sancak, Y., C. C. Thoreen, T. R. Peterson, R. A. Lindquist, S. A. Kang, E. Spooner, S. A. Carr, and D. M. Sabatini. 2007. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25:903-915.
67. Sarbassov, D. D., S. M. Ali, and D. M. Sabatini. 2005. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17:596-603.
68. Saucedo, L. J., X. Gao, D. A. Chiarelli, L. Li, D. Pan, and B. A. Edgar. 2003. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 5:566-571.
69. Schalm, S. S., D. C. Fingar, D. M. Sabatini, and J. Blenis. 2003. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13:797-806.
70. Sette, C., and M. Conti. 1996. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271:16526-16534.
71. Sette, C., S. Iona, and M. Conti. 1994. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem. 269:9245-9252.
72. Shaywitz, A. J., and M. E. Greenberg. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-861.
73. Souness, J. E., D. Aldous, and C. Sargent. 2000. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 47:127-162.
74. Souness, J. E., and S. Rao. 1997. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell. Signal. 9:227-236.
75. Stefan, E., B. Wiesner, G. S. Baillie, R. Mollajew, V. Henn, D. Lorenz, J. Furkert, K. Santamaria, P. Nedvetsky, C. Hundsrucker, M. Beyermann, E. Krause, P. Pohl, I. Gall, A. N. MacIntyre, S. Bachmann, M. D. Houslay, W. Rosenthal, and E. Klussmann. 2007. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J. Am. Soc. Nephrol. 18:199-212.
76. Stocker, H., T. Radimerski, B. Schindelholz, F. Wittwer, P. Belawat, P. Daram, S. Breuer, G. Thomas, and E. Hafen. 2003. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5:559-565.
77. Stork, P. J., and J. M. Schmitt. 2002. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12:258-266.
78. Suh, J. M., J. H. Song, D. W. Kim, H. Kim, H. K. Chung, J. H. Hwang, J. M. Kim, E. S. Hwang, J. Chung, J. H. Han, B. Y. Cho, H. K. Ro, and M. Shong. 2003. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J. Biol. Chem. 278:21960-21971.
79. Sun, Y., Y. Fang, M. S. Yoon, C. Zhang, M. Roccio, F. J. Zwartkruis, M. Armstrong, H. A. Brown, and J. Chen. 2008. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. U. S. A. 105:8286-8291.
80. Sutherland, E. W., and T. W. Rall. 1958. Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J. Biol. Chem. 232:1077-1091.
81. Tasken, K., and E. M. Aandahl. 2004. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84:137-167.
82. Tasken, K. A., P. Collas, W. A. Kemmner, O. Witczak, M. Conti, and K. Tasken. 2001. Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J. Biol. Chem. 276:21999-22002.
83. Taylor, S. S., C. Kim, C. Y. Cheng, S. H. Brown, J. Wu, and N. Kannan. 2008. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim. Biophys. Acta 1784:16-26.
84. Tee, A. R., B. D. Manning, P. P. Roux, L. C. Cantley, and J. Blenis. 2003. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13:1259-1268.
85. Terry, R., Y. F. Cheung, M. Praestegaard, G. S. Baillie, E. Huston, I. Gall, D. R. Adams, and M. D. Houslay. 2003. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process. Cell. Signal. 15:955-971.
86. Vander Haar, E., S. I. Lee, S. Bandhakavi, T. J. Griffin, and D. H. Kim. 2007. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9:316-323.
87. Verde, I., G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S. L. Jin, and M. Conti. 2001. Myomegalin is a novel protein of the Golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J. Biol. Chem. 276:11189-11198.
88. Wang, H., M. S. Peng, Y. Chen, J. Geng, H. Robinson, M. D. Houslay, J. Cai, and H. Ke. 2007. Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem. J. 408:193-201.
89. Willoughby, D., G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. Cooper. 2007. Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during beta2-adrenoceptor and prostanoid receptor cAMP signaling. J. Biol. Chem. 282:34235-34249.
90. Wong, W., and J. D. Scott. 2004. AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5:959-970.
91. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471-484.
92. Xu, L., C. R. Sterling, and A. W. Tank. 2009. cAMP-mediated stimulation of tyrosine hydroxylase mRNA translation is mediated by polypyrimidine-rich sequences within its 3′-untranslated region and poly(C)-binding protein 2. Mol. Pharmacol. 76:872-883.
93. Yamagata, K., L. K. Sanders, W. E. Kaufmann, W. Yee, C. A. Barnes, D. Nathans, and P. F. Worley. 1994. rheb, a growth factor- and synaptic activityregulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 269:16333-16339.
94. Yarwood, S. J., M. R. Steele, G. Scotland, M. D. Houslay, and G. B. Bolger. 1999. The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J. Biol. Chem. 274:14909-14917.
95. Yin, W., J. Mu, and M. J. Birnbaum. 2003. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J. Biol. Chem. 278:43074-43080.
96. Zhang, Y., X. Gao, L. J. Saucedo, B. Ru, B. A. Edgar, and D. Pan. 2003. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5:578-581.